ProfileGDS4718 / 202902_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 99% 73% 98% 99% 93% 95% 98% 99% 98% 98% 98% 97% 95% 96% 98% 99% 97% 95% 85% 98% 99% 99% 98% 97% 96% 99% 83% 99% 95% 95% 96% 98% 98% 95% 95% 96% 98% 98% 76% 98% 93% 95% 84% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.014597
GSM549102patient 115, normal, homogenized [OPG study]11.926199
GSM549104patient 119, normal, homogenized [OPG study]7.1599773
GSM549108patient 138, normal, homogenized [OPG study]11.543898
GSM549119patient 077, normal, homogenized [OPG study]12.080899
GSM549133patient 032, cancer, homogenized [OPG study]9.8655493
GSM549139patient 042, cancer, homogenized [OPG study]10.186295
GSM549099patient 107, normal, homogenized [OPG study]11.621198
GSM549109patient 139, normal, homogenized [OPG study]12.332699
GSM549110patient 046, normal, homogenized [OPG study]11.88998
GSM549114patient 063, normal, homogenized [OPG study]11.765398
GSM549122patient 082, normal, homogenized [OPG study]11.430498
GSM549134patient 033, cancer, homogenized [OPG study]10.867497
GSM549136patient 036, cancer, homogenized [OPG study]10.198795
GSM549140patient 044, cancer, homogenized [OPG study]10.506596
GSM549111patient 047, normal, homogenized [OPG study]11.720398
GSM549113patient 057, normal, homogenized [OPG study]12.454399
GSM549132patient 031, cancer, homogenized [OPG study]10.653697
GSM549137patient 038, cancer, homogenized [OPG study]10.151195
GSM549142patient 047, cancer, homogenized [OPG study]8.0978385
GSM549100patient 110, normal, homogenized [OPG study]11.264198
GSM549107patient 135, normal, homogenized [OPG study]12.170699
GSM549115patient 068, normal, homogenized [OPG study]12.098699
GSM549116patient 072, normal, homogenized [OPG study]11.830798
GSM549120patient 078, normal, homogenized [OPG study]11.132797
GSM549131patient 030, cancer, homogenized [OPG study]10.689596
GSM549118patient 074, normal, homogenized [OPG study]12.070599
GSM549129patient 027, cancer, homogenized [OPG study]8.1989983
GSM549123patient 088, normal, homogenized [OPG study]12.148899
GSM549124patient 006, cancer, homogenized [OPG study]9.9589495
GSM549126patient 015, cancer, homogenized [OPG study]10.258295
GSM549128patient 025, cancer, homogenized [OPG study]10.423796
GSM549103patient 117, normal, homogenized [OPG study]11.589798
GSM549117patient 073, normal, homogenized [OPG study]11.978698
GSM549138patient 041, cancer, homogenized [OPG study]10.130895
GSM549141patient 045, cancer, homogenized [OPG study]10.322695
GSM549130patient 028, cancer, homogenized [OPG study]10.241696
GSM549101patient 111, normal, homogenized [OPG study]11.697798
GSM549105patient 128, normal, homogenized [OPG study]11.696798
GSM549106patient 134, normal, homogenized [OPG study]7.5288776
GSM549112patient 048, normal, homogenized [OPG study]12.028498
GSM549125patient 011, cancer, homogenized [OPG study]9.759693
GSM549127patient 024, cancer, homogenized [OPG study]10.230595
GSM549135patient 035, cancer, homogenized [OPG study]8.4741284